Neogenomics Inc NEO

US Health Care

$15.29 ▼ -3.72% ($-0.59)

Open $15.78

Prev Close $15.88

Day Range $15.27 – $15.90

52W Range $4.72 – $16.17

Market Cap $1.96B

Beta 1.78

EPS (TTM) $-0.77

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2012-12-10
Shares Out.	128,480,000
Website	neogenomics.com/ ↗
Phone	12397680600
Employees	2,500
Revenue	$201.7M
Gross Profit	$91.9M
Net Income	$2.2M
Free Cash Flow	-$7.4M
Total Assets	$1.35B
Total Liabilities	$566.5M
Equity	$785.7M

About Neogenomics Inc

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Neogenomics Inc is a publicly traded company under the ticker symbol NEO on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.